The ecosystem supporting the translation of basic discoveries into clinical innovations has evolved dramatically in the past decades. And the rate of change is not slowing down. Increasingly, we see novel models of partnerships between academia, venture capital, private companies, patient organizations and governments. A better knowledge of this ecosystem is becoming a key skill. This workshop is for all pharmaceutical scientist interested in translational research. Participants will learn how current key models of partnership are set up to support the development of discoveries towards the clinic.
Collaborative models in drug R&D: the transformative changes ahead
Bernard Munos Senior Fellow, FasterCures
Leading academia across the valley of death
Steven Klein, VP B-D, IRICoR
Precompetitive research to improve the R&D landscape
Nadia Dubé, CQDM
How venture capital can help
Inès Holzbaur, Amorchem
Translating our research excellence into an industry of scale
Mounia Azzi, AdMare BioInnovations
Academic researchers, industry scientists and clinicians.
Scientists with a project that may benefit from translational research support.
Certificate of attendance for all (delivered by FIP)